The rest of the world is going to help U.S. consumer product manufacturers next year. Look for international growth to push the likes of Colgate-Palmolive (CL), Avon (AVP) and Clorox (CLX) higher in 2010, according to Fitch Ratings. In an interview with Reuters, a director gave the Fitch's outlook for consumer goods.

The household and personal care segments increased revenue every year from 2003 to 2008. So, 2009 was but a bump in the road. Even in a recession, you need toilet paper and shampoo, so expect the spending to come back.

The Street.com's Jim Cramer says that OPEC may take oil out of the equity-market equation and make stock-picking matter again.

If OPEC says it likes an oil price in the $75-78 range, as it said today, we could be looking at a nirvana moment for stocks. We know that any time oil bounces, the S&P 500 futures go up. Any time it goes down, the S&P futures go down. But if OPEC wants to keep it right here, we take oil out of the equation and make stock-picking matter again.

Right now, the Saudis are telling the big oil-shipping companies that they want to bring 1 million barrels a day into the market straight away to keep oil below $80. That can be used to overwhelm the speculators who are tying up as much as 20% of the oil fleet in the world to keep oil off the market and buoy its price. But they will not bring the oil to the market below $75.

Clorox (NYSE: CLX), a consumer-products business that counts Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL) as related stocks, may have seen a sales drop of 1% in its fiscal first quarter, but that didn't stop it from posting a nice bottom-line growth rate. Clorox made $1.11 per share in Q1, and that represents a 23% increase. What a way to start a new corporate year!

According to Reuters, expectations were for 95 cents per share. That's a wonderful beat. Plus, sales volume went up 1%. Helping to drive things along was a healthy gross margin, as well as the dreaded H1N1 virus. Clorox has done well over the years associating its brand with sanitizing effectiveness, so when a pandemic rears its ugly head, the trademark is prepared to leverage such reputation to drive value.

Stocks suffered a scary drop on Friday. It was fitting, in a sense, since it was the day before Halloween. In fact, as this Closing Bell piece noted, there were more tricks than treats to be had on Wall Street.

There are always equities bucking the trend, however. The Estee Lauder Companies (NYSE: EL) was one of them. Bullish buyers loved the beauty company's fiscal Q1 earnings release. As has been the case with many reports, the top line wasn't the fun part of the document: Estee Lauder saw a decrease of 2.7% for adjusted revenues. Here's the item of interest: net income after charges was 85 cents per share, more than three times what was made in the comparable frame.

Consumer spending had its largest fall this year, thanks to the end of the "Cash for Clunkers" program. And, incomes were flat. No change to the money coming in and a drop in the cash going out translates to an impediment to economic recovery.

In September, consumer spending fell 0.5%, the first decline in five months and the worst in nine. Wages and salaries dropped 0.2%, effectively offsetting the 0.2% up-tick in August. The economy did grow in the third quarter of 2009, hinting that the worst recession in 70 years may be coming to a close, but the tough September suggests we still have some work in front of us.

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Aflac Inc. (NYSE: AFL) reported strong Q3 results, declared a dividend, and offered guidance for Q4.
• Avon Products Inc. (NYSE: AVP) Q3 earnings slumped and revenue was hurt by currency translations.
• BP (NYSE: BP) shares leaped higher after it reported better-than-expected quarterly earnings.
• Daimler AG (NYSE: DAI) reported that it returned to profitability in Q3 but warned of decreasing revenue.
• General Dynamics Corp. (NYSE: GD) Q3 earnings beat expectations and it lifted its earnings outlook.
• Hershey Co. (NYSE: HSY) posted strong Q3 earnings and expects full-year earnings ahead of forecasts.

Avon Products (NYSE: AVP) had a difficult third quarter. Currency translations helped to drive a 4% decrease in net revenue. Excluding that effect, sales were up 7%. Net income decreased a big 31% to 36 cents per share.

However, according to Reuters, adjusted earnings of 42 cents per share beat analyst projections by two pennies. Such news didn't seem to matter to the market. At the time of this writing, Avon was down 1.9% on significant volume.

Today was all about much better than expected GDP reports. The lackluster jobless claims failed to even make a ripple after the GDP marked an unofficial end of the recession. The market absorbed over $500 million in secondary offerings like it was a stick of butter being put on a giant baked potato.

Here were today's unofficial closing bell levels:

Dow 9,960.54 +197.85 (2.03%)
S&P 500 1,065.81 +23.18 (2.22%)
Nasdaq 2,097.55 +37.94 (1.84%)

Top 10 Analyst Calls
Top Stock Rumors

Before the opening bell sounds on Thursday, October 29, Cincinnati-based Dow component Procter & Gamble (NYSE: PG) will report fiscal first-quarter earnings. Analysts believe P&G will report earnings of 99 cents per share with sales of $19.83 billion.

These expected results are lower than those of a year ago, when the company saw earnings of $1.03 per share and revenue of $22 billion. P&G set expectations low for this quarter, as it announced early in the quarter that sales are expected to fall again. Is this truly the case or is it a smart business move?

Kimberly-Clark Corporation (NYSE: KMB), a consumer products entity whose colleagues include Procter & Gamble (NYSE: PG) and Johnson & Johnson (NYSE: JNJ), is up today on third-quarter results. At the time of this writing, my screen was showing shares of Kimberly-Clark higher by a little under 6%.

According to the corporate press release, sales declined 1.7%. Not a great start, but Kimberly-Clark highlighted a better metric: organic sales increased 3%, helped along by price increases. Luckily, sales volume didn't fare too badly; they were essentially flat.

Since the stock market bottomed in March of this year, it has been firing on all cylinders -- except for those in the auto industry who manufacture the most cylinders of course. This year has not been kind to them.

For months, many have been surprised at the rapid rise, given the level of unemployment. During this same period, Wall Streeters have been dancing up and down, looking forward to more bonuses.

As the number of unemployed has climbed and the period of same has lengthened, many have wondered how business could be improving during a time when the consumer (those still left) has transformed from spender to saver.

Johnson & Johnson (NYSE: JNJ), the New Jersey-based health care giant, is scheduled to hold an analyst meeting to discuss its third quarter 2009 financial results Tuesday at 8:30 AM ET, hosted by CFO Dominic Caruso and others. You can catch the live broadcast of the meeting on the company's website.

During the three months that ended in September, Johnson & Johnson completed a biotech acquistion and announced a collaboration to combat the flu. Analysts surveyed by Thomson Reuters expect this dividend-paying company to report that net income fell three cents per share from a year ago to $1.13. Revenue for the period is expected to be 4.6% lower to $15.2 billion.

One of my wonderful friends, Ms. P, asked me for some guidance on how she might allocate $50,000 currently earning peanuts in a money market account. Though she is decades from becoming a grandmother, after a brief discussion about her financial parameters, it became clear to me that she was looking for a "granny fund."

In reality, my recommendations would be suitable, and perhaps desirable, for many passive investors as well.

The $50,000 is a portion of money Ms. P has set aside to purchase a home, which might happen in six months, but could also be pushed out further, depending on the economy and her situation. Basically, she wants to cover all her bases because she might need the money at any time and does not want to be caught short, while at the same time she would like to generate some revenue without taking any big risks.

Analyst upgrades:

• FBR Capital upgraded McAfee (NYSE: MFE) to Outperform from Market Perform after channel checks indicated the company's September quarter deal flow has been stronger than expected. FBR raised its target on shares to $50 from $41.
• Thomas Weisel upgraded Adtran (NASDAQ: ADTN) to Overweight from Market Weight, citing increased wireless backhaul capex spending by Tier-1 carriers. The firm raised its target to $32 from $21.
• RBC Capital upgraded Brunswick (NYSE: BC) to Outperform from Sector Perform as the firm thinks the company no longer has liquidity risk and can generate significant profits by 2012. The firm set a $17 target on the stock.
• Bronco Drilling (NASDAQ: BRNC) was upgraded to Hold from Underperform at Jefferies.
• LSI Corp. (NYSE: LSI) was upgraded to Buy from Hold at Deutsche Bank.
• UBS upgraded U.S. Airways (NYSE: LCC) and UAL Corp. (NASDAQ: UAUA) to Buy from Neutral.

Analyst upgrades:

• Citigroup upgraded Procter & Gamble (NYSE:PG) to Buy from Hold after meeting with management as it believes a more aggressive strategy will lead to the company regaining market share. Citi raised its target on shares to $66 from $54.
  
• Piper Jaffray upgraded Allscripts (NASDAQ:MDRX) to Overweight from Neutral after learning the company signed a large contract with North Shore Long Island Jewish Hospital. Piper now sees upside to estimates and raised its target on shares to $22.50 from $14.
  
• UBS upgraded Amedisys (NASDAQ:AMED) to Buy from Neutral following a review of the Senate Finance Committee's healthcare proposal, which they view as "benign." The firm raised its target to $57 from $46.
• Daimler (NYSE:DAI) was upgraded to Outperform from Market Perform at Bernstein.
  
• Boston Private (NASDAQ:BPFH) was upgraded to Outperform from Market Perform at Keefe Bruyette.
  
• E-Trade (NASDAQ:ETFC) was upgraded to Buy from Neutral at Goldman.